טאלץ 80 מג Israeli - Kiebrania - Ministry of Health

טאלץ 80 מג

eli lilly israel ltd, israel - ixekizumab - תמיסה להזרקה - ixekizumab 80 mg / 1 ml - ixekizumab

טרנדייט טבליות 100 מג Israeli - Kiebrania - Ministry of Health

טרנדייט טבליות 100 מג

padagis israel agencies ltd, israel - labetalol hydrochloride - טבליה - labetalol hydrochloride 100 mg - labetalol - labetalol - treatment of all grades of hypertension (mild, moderate and severe) when oral antihypertensive therapy is desirable.

טריטייס  קומפ 2.5 מג  12.5 מג Israeli - Kiebrania - Ministry of Health

טריטייס קומפ 2.5 מג 12.5 מג

sanofi israel ltd - hydrochlorothiazide; ramipril - טבליה - ramipril 2.5 mg; hydrochlorothiazide 12.5 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. tritace comp is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

טריטייס קומפ 5 מג  25 מג Israeli - Kiebrania - Ministry of Health

טריטייס קומפ 5 מג 25 מג

sanofi israel ltd - hydrochlorothiazide; ramipril - טבליה - ramipril 5 mg; hydrochlorothiazide 25 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. tritace comp is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

קו-דיובאן 8012.5 מג טבליות מצופות Israeli - Kiebrania - Ministry of Health

קו-דיובאן 8012.5 מג טבליות מצופות

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 80 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension for patients in whom combination therapy is appropriate.

קו-דיובאן 16012.5 מג טבליות מצופות Israeli - Kiebrania - Ministry of Health

קו-דיובאן 16012.5 מג טבליות מצופות

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 160 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

קו-דיובאן 16025 מג טבליות מצופות Israeli - Kiebrania - Ministry of Health

קו-דיובאן 16025 מג טבליות מצופות

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 160 mg; hydrochlorothiazide 25 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

פרופס Israeli - Kiebrania - Ministry of Health

פרופס

ferring pharmaceuticals ltd - dinoprostone - התקן תוך נרתיקי - dinoprostone 10 mg - dinoprostone - dinoprostone - initiation and/or continuation of cervical ripening in patients at term, from 38th week of gestation, with bishop score of 6 or less.

אטוסיבן - פרינג Israeli - Kiebrania - Ministry of Health

אטוסיבן - פרינג

ferring pharmaceuticals ltd - atosiban - solution for injection - atosiban 7.5 mg/ml - atosiban - atosiban - atosiban is indicated to delay imminent pre-term birth in pregnant women with: - regular uterine contractions of at least 30 seconds duration at a rate of 4 or more per 30 minutes - a cervical dilation of 1 to 3 cm (0-3 for iparas) and effacement of 50 % or more - age: 18 years and above - a gestational age from 24 until 33 completed weeks - a normal foetal heart rate.

בלארה Israeli - Kiebrania - Ministry of Health

בלארה

tec-o-pharm-libra ltd - chlormadinone acetate; ethinylestradiol - טבליות מצופות פילם - ethinylestradiol 0.03 mg; chlormadinone acetate 2 mg - etynodiol and estrogen - etynodiol and estrogen - oral hormonal contraceptive.